Docplexus is happy to share with you our new offering " M edical E vi D ence based F actual A nalysis of C linical T rials ( MED FACT ) ". This weekly edition will provide you with the Critical Summary of latest Publications in your specialty presented in high indexed International Journals. This week's 'MED FACT' discusses a clinical trial from Osteoarthritis and Cartilage Journal, “A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – The HUMOR trial”. Authors: Dawn Aitken, Laura L.
Laslett, Feng Pan, Ida K. Haugen, Petr Otahal, Nicholas Bellamy, Paul Bird, Graeme Jones Synopsis Erosive hand osteoarthritis (OA) is considered as a major inflammatory hand OA phenotype. Patients’ with high level of disability and pain are often difficult to treat. Chevalier et al reported that adalimumab treatment was not…
